Your research cart is empty.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.
High-purity, structurally verified peptide sequences for advanced laboratory and pre-clinical applications.
FOXO4-DRI is a D-amino acid retro-inverso peptide (DRI) and p53-interaction domain analog. With the molecular formula C₂₂₈H₃₉₀N₈₆O₇₅S₂ and a molecular weight of 5358.1 g/mol (CAS: 1449830-41-4), it st...
Lab Verified
Clinical Grade
PMID Cited
Published preclinical research has characterized the following molecular pathways and receptor interactions for FOXO4.
Published research demonstrates FOXO4-DRI modulates targeted signaling cascades within cell tissue models (PMID: 40593617).
In cellular environments, FOXO4-DRI exhibits selective binding and corresponding pathway activation (PMID: 34877934).
Bourgeois et al. (2025) investigated FOXO4-DRI's binding affinity and receptor interactions in vitro (PMID: 40593617).
Meng et al. (2021) investigated FOXO4-DRI's binding affinity and receptor interactions in vitro (PMID: 34877934).
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
GH SecretagoguesC152H252N44O42 · 3367.9 g/mol
For in vitro research use only. Not for human consumption.
GH SecretagoguesBlend · Mixed
For in vitro research use only. Not for human consumption.
GH SecretagoguesC38H49N9O5 · 711.87 g/mol
For in vitro research use only. Not for human consumption.